BenevolentAI combines AI and machine learning with science to decipher complex disease biology, generate novel insights and discover more effective medicines. Its computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programs from early discovery towards clinical phases. With several successful collaborations with leading pharmaceutical organizations, BenevolentAI is the only AI-drug discovery company with a clinically validated approach, having discovered a leading repurposed drug candidate for COVID-19.
BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.
Ken Mulvany, Brent Gutekunst, Ivan Griffin and Michael Brennan founded Stratified Medicine in November 13, 2013 in London, United Kingdom. The company changed its name to BenevolentAI in Sepetember 2016. It has offices in Cambridge, Belgium and New York.
#GBMDay: An AI-Enabled Approach to GBM Drug Discovery
July 29, 2021
AI Uncovers a Potential Treatment for Covid-19 Patients
April 17, 2020
AI: The Next Revolution In Medicine?
January 23, 2019
AstraZeneca scores new goal on the pipeline front, adding its first AI-generated target to the portfolio
January 27, 2021
BenevolentAI & AstraZeneca: Fusing AI and Drug Discovery Expertise to Find New Treatments for CKD
April 8, 2021
- CompanyA company, abbreviated as "Co." within a company name, is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- BioinformaticsInterdisciplinary field that applies computational techniques to solve biological problems on the molecular level.
- StartupA startup company is an entrepreneurial venture in the initial stage of its operations. Startups are typically young businesses aiming to grow quickly and meet a marketplace need by developing or offering an innovative product, process or service.
- Unicorn (finance)A privately held startup company with a valuation above $1 billion.